Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.37 |
| ▸ | VHL | P40337 | 1/20 | 0.36 |
| ▸ | AGBL2 | Q5U5Z8 | 1/20 | 0.36 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25522414 | 0.84 | ALDH1A1 (0.50) | KDM4EPKMALDH1A1KMT2AMEN1 | |
| SCHEMBL3091813 | 0.82 | ALDH1A1 (0.48) | KDM4EPKMALDH1A1KMT2AMEN1 | |
| SCHEMBL1074418 | 0.81 | ALDH1A1 (0.56) | KDM4EPKMALDH1A1KMT2AMEN1 | |
| Bicarbonate SCHEMBL27829730 | 0.80 | KDM4E (0.52) | KDM4EPKMALDH1A1KMT2AMEN1 | |
| SCHEMBL25562762 | 0.79 | ALDH1A1 (0.46) | KDM4EPKMALDH1A1KMT2AMEN1 | |
| SCHEMBL7779172 | 0.78 | ALDH1A1 (0.53) | KDM4EPKMALDH1A1KMT2AMEN1 | |
| SCHEMBL27400464 | 0.78 | SMN1; SMN2 (0.46) | KDM4EPKMALDH1A1KMT2AMEN1 | |
| SCHEMBL27650993 | 0.76 | GABRA5 (0.43) | KDM4EPKMALDH1A1KMT2AMEN1 | |
| Acetic Acid SCHEMBL3851421 | 0.76 | ALDH1A1 (0.55) | KDM4EPKMALDH1A1KMT2AMEN1 | |
| SCHEMBL4236238 | 0.75 | KDM4E (0.43) | KDM4EPKMALDH1A1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118234414-A | Nut butter imitation produced from separate components | 航行食品股份有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-113699077-A | Microbial degradation method of vomitoxin | 河南工业大学 | 2021-11-26 | — | — | CN | disclosed |
| CN-108473484-B | Compounds useful as TRPM8 modulators | 弗门尼舍公司 | 2021-06-29 | — | — | CN | disclosed |
| CN-103189370-A | Triazole derivatives as ligands for GABA receptors | HOFFMANN LA ROCHE | 2013-07-03 | — | — | CN | disclosed |
| EP-1689256-B1 | FOOD PRODUCTS CONTAINING A FRUIT COMPONENT | TAKASAGO PERFUMERY CO LTD (JP) | 2011-07-27 | — | — | EP | disclosed |
| EP-1351934-B1 | NAPHTHALENE DERIVATIVES WHICH BIND TO THE EP4 RECEPTOR | GLAXO GROUP LTD (GB) | 2007-08-29 | — | — | EP | disclosed |
| US-20070092623-A1 | Food products containing a fruit component | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-04-26 | — | — | US | disclosed |
| EP-1689256-A1 | FOOD PRODUCTS CONTAINING A FRUIT COMPONENT | Takasago International Corporation (JP) | 2006-08-16 | — | — | EP | disclosed |
| US-6924297-B2 | Naphathalene derivatives which bind to the EP4 receptor | SMITHKLINE BEECHAM CORPORATION (US) | 2005-08-02 | — | — | US | disclosed |
| WO-2005048743-A1 | FOOD PRODUCTS CONTAINING A FRUIT COMPONENT | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2005-06-02 | — | — | WO | disclosed |
| US-20040102508-A1 | Naphathalene derivatives which bind to the ep4 receptor | SMITHKLINE BEECHAM CORPORATION | 2004-05-27 | — | — | US | disclosed |
| EP-1351934-A1 | NAPHTHALENE DERIVATIVES WHICH BIND TO THE EP4 RECEPTOR | GLAXO GROUP LIMITED (GB) | 2003-10-15 | — | — | EP | disclosed |
| WO-2002050032-A1 | NAPHTHALENE DERIVATIVES WHICH BIND TO THE EP4 RECEPTOR | GLAXO GROUP LIMITED (GB) | 2002-06-27 | — | — | WO | disclosed |
| EP-0397048-A2 | Process for the preparation of 2-mercapto-4-methyl-1,3-thiazol-5-yl acetic acid and its esters | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-11-14 | — | — | EP | disclosed |
| US-4665066-A | BACTERICIDES | ELI LILLY AND COMPANY (US) | 1987-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040102508-A1 | Naphathalene derivatives which bind to the ep4 receptor | PTGER4, PTGER1, PTGER3 | KDM4E 3281/4885PKM 2285/4885ALDH1A1 1587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.